Short Term Price Target on Amyris (AMRS)

Amyris (NASDAQ:AMRS) : The consensus price target for Amyris (NASDAQ:AMRS) is $2.63 for the short term with a standard deviation of $1.94. The most optimist securities analyst among the 2 who monitor the stock believes that the stock can reach $4, however, the pessimist price target for the company is $1.

Shares of Amyris, Inc. appreciated by 12.63% during the last five trading days but lost 16.57% on a 4-week basis. Amyris, Inc. has dropped 58.67% during the last 3-month period . Year-to-Date the stock performance stands at -72.19%.

Amyris (NASDAQ:AMRS) : The consensus on Amyris (NASDAQ:AMRS) based on 3 analyst recommendation on the company stock is 2.33, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 1 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

Amyris (NASDAQ:AMRS): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $0.43 and $0.40 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $0.48. The buying momentum continued till the end and the stock did not give up its gains. It closed at $0.45, notching a gain of 10.12% for the day. The total traded volume was 4,615,534 . The stock had closed at $0.41 on the previous day.

In an insider trading activity, Doerr L John, director of Amyris, Inc. had purchased 200,577 shares on June 14, 2016 in a transaction. The price per share was $1.04 and the total amount of the disclosed transaction was $208,600.The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing. This information is based on open market transaction at the market prices.

Amyris, Inc. is a renewable products company. The Company is focused on providing sustainable alternatives to a range of petroleum-sourced products used in consumer care, specialty chemical and transportation fuel markets around the world. The Company developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company using its industrial bioscience technology to design microbes, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company has focused its commercialization efforts on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products including emollients, flavors and fragrance oils and diesel fuel.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.